文献速递胃肠外科围术期管理与 ERAS

CALLY指数作为胃癌手术预后综合炎症-营养-免疫标志物

The CALLY index as a comprehensive inflammation-nutrition-immunity marker for prognosis in gastric cancer surgery.
PubMed 文献 · Surg Endosc · 2026-02-23

该单中心回顾性队列研究纳入992例根治性胃切除胃癌患者并设302例时间验证队列,评估术前CALLY指数预后价值。CALLY对5年OS的AUC为0.708,低CALLY与更差OS和DFS独立相关,并与术后并发症风险独立相关。

要点

  • 术前CALLY指数可独立预测胃癌根治术后长期生存和短期并发症。
  • CALLY对5年OS的区分能力与mGPS相当,略优于其他炎症-营养指标。
  • 低CALLY与OS和DFS较差独立相关,验证队列方向一致。

核心结论

  • 术前CALLY指数可独立预测胃癌根治性胃切除患者的长期生存和短期术后并发症。
  • 与传统炎症-营养评分相比,CALLY在多个终点上表现相当至略优且更一致,但区分度绝对增益有限。

研究设计与样本

  • 单中心回顾性队列研究,开发队列992例,时间验证队列302例,均为接受根治性胃切除的胃腺癌连续患者。
  • 术前1周内实验室参数用于计算CALLY指数,采用ROC分析、Kaplan-Meier法、多变量Cox回归和多变量logistic回归分析。

主要发现

  • 开发队列中CALLY最佳截断值为2.61。
  • 5年OS的AUC:CALLY为0.708,与mGPS(AUC=0.705)相当,优于其他指标(AUC≤0.675)。
  • 低CALLY与较差的OS和DFS显著相关(均p<0.001),多变量调整后仍为独立预后因素(OS HR 1.56,95%CI 1.20-2.03;DFS HR 1.48,95%CI 1.16-1.90)。
  • 低CALLY与总体和严重术后并发症风险增加独立相关,验证队列方向一致。

临床怎么用

  • 术前可计算CALLY指数辅助胃癌根治术患者的预后风险分层。
  • 低CALLY患者可能需加强围术期并发症防范和术后随访。

局限性

  • 单中心回顾性设计,需前瞻性多中心验证。
  • 需标准化检测方法、预设分析和重新校准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reliable preoperative prognostic tools that comprehensively reflect host-related factors remain limited for gastric cancer (GC). The C-reactive protein-albumin-lymphocyte (CALLY) index integrates systemic inflammation, nutritional status, and immune competence. We evaluated its prognostic performance compared with commonly used inflammation-nutrition indices. METHODS: We conducted a single-center retrospective cohort study of consecutive patients undergoing curative gastrectomy for gastric adenocarcinoma, with temporal validation. Preoperative laboratory parameters obtained within 1 week before surgery were used to calculate the CALLY index. Outcomes included overall survival (OS), disease-free survival (DFS), and 30 day postoperative morbidity. Discrimination was assessed using receiver operating characteristic (ROC) analysis; survival outcomes were analyzed using Kaplan-Meier methods and multivariable Cox regression; postoperative morbidity was evaluated using multivariable logistic regression. RESULTS: The development cohort included 992 patients, and the temporal validation cohort included 302 patients. In the development cohort, the optimal CALLY cutoff was 2.61. For 5 year OS, the CALLY index showed the highest discriminative ability (AUC = 0.708), comparable to mGPS (AUC = 0.705) and superior to other indices (AUC ≤ 0.675). A low CALLY index was significantly associated with poorer OS and DFS (both p < 0.001) and remained independently prognostic after multivariable adjustment (OS HR 1.56, 95% CI 1.20-2.03; DFS HR 1.48, 95% CI 1.16-1.90). Low CALLY was also independently associated with increased risks of overall and severe postoperative complications, with consistent directions observed in the validation cohort. CONCLUSIONS: The preoperative CALLY index independently predicts long-term survival and short-term postoperative morbidity in patients with GC undergoing curative gastrectomy. Compared with conventional inflammation-nutrition scores, CALLY shows comparable-to-slightly better and more consistent prognostic performance across endpoints, although absolute gains in discrimination are modest. Prospective multicenter validation with standardized assays, prespecified analyses, and recalibration is warranted.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Liu G, Zhao S, Xia M, et al. The CALLY index as a comprehensive inflammation-nutrition-immunity marker for prognosis in gastric cancer surgery. Surg Endosc. 2026. PMID: 41731142. doi:10.1007/s00464-026-12665-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。